Aurora Cannabis Inc income statement

In fiscal 2026, Aurora Cannabis Inc reported revenue of $232m, up 11.7% on the year before and net income of −$98.4m, or −$1.55 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aurora Cannabis Inc: income statement, annual
Fiscal year	2019Jun 2018	2020Jun 2019	2021Jun 2020	2022Jun 2021	2023Jun 2022	2024Mar 2024	2025Mar 2025	2026Mar 2026
Revenue	43	186	200	191	175	200	208	232
Gross profit	34	108	−15	−17	17	98	130	99
Research and development	1	11	19	9	8	3	3	3
Operating income	−75	−240	−347	−221	−183	−33	4	—
Interest expense	0	5	4	4	3	5	6	5
Income before tax	61	−250	−2,489	−546	−1,359	−43	23	−41
Income tax	6	−23	−61	−5	−2	−0	3	2
Net income	57	−222	−2,446	−540	−1,357	−51	1	−98
Diluted EPS	$7.09	−$13.15	—	−$16.01	−$31.57	−$1.13	$0.03	−$1.55
Diluted shares (average)	8m	17m	19m	34m	43m	43m	56m	57m
EBITDA	−66	−193	−297	−182	−144	−25	6	—

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ACB vs VNDA ACB vs HROW ACB vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Aurora Cannabis Inc's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aurora Cannabis Inc.